OCGN
Ocugen, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Shankar Musunuri
IPO Date
2014-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Ocugen, Inc.
CEO
Shankar Musunuri
IPO Date
2014-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 112,205 |
| $0.46 |
| 2 Apr 2026 | Zhang Junge | director | M-Exempt | Acquired | 66,929 | $1.42 |
| 2 Apr 2026 | Zhang Junge | director | M-Exempt | Disposed | 15,000 | $0.51 |
| 2 Apr 2026 | Zhang Junge | director | M-Exempt | Disposed | 112,205 | $0.46 |
| 2 Apr 2026 | Zhang Junge | director | M-Exempt | Disposed | 66,929 | $1.42 |
| 5 Mar 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Disposed | 0 | $0.00 |
| 5 Mar 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Disposed | 0 | $0.00 |
| 5 Mar 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Disposed | 750,000 | $1.44 |
| 6 Jan 2026 | Musunuri Shankar | director, officer: Chief Executive Officer | A-Award | Acquired | 3,123,201 | $0.00 |